HCA
IART icon

Harbor Capital Advisors’s Integra LifeSciences IART Stock Holding History

Harbor Capital Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-703
Closed -$9K – 1354
2025
Q4 		$9K Sell
703
-12
-2% -$160 ﹤0.01% 973
2025
Q3 		$10K Buy
715
+395
+123% +$5.41K ﹤0.01% 953
2025
Q2 		$4K Sell
320
-141
-31% -$2.05K ﹤0.01% 1218
2025
Q1 		$10K Buy
461
+138
+43% +$3.25K ﹤0.01% 960
2024
Q4 		$7K Buy
323
+49
+18% +$1.07K ﹤0.01% 1055
2024
Q3 		$5K Buy
+274
New +$6.35K ﹤0.01% 1127

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Harbor Capital Advisors's IART Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 703 shares — an estimated $9K sold.

Harbor Capital Advisors first reported a position in IART in Q3 2024 and held it in 6 quarters. The position peaked at $10K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 703 Integra LifeSciences shares in Q1 2026, an estimated $9K.
  • Harbor Capital Advisors first reported a position in Integra LifeSciences in Q3 2024 and held it in 6 quarters.
  • Harbor Capital Advisors's Integra LifeSciences position peaked at $10K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.